Individual NGS methods come with their own pros and cons, but automation optimization solutions exist for all NGS workflows.
Twist Bioscience recently reported fourth-quarter and full-year fiscal 2025 results, highlighting record revenue of US$99.01 million and strong double-digit growth across synthetic biology, biopharma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback